rs928883
|
MIR155HG
|
Mucosa-Associated Lymphoid Tissue Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Variant rs928883, near miR-155, showed an association (OR per A-allele: 2.80 [95% CI: 1.63-4.82]; p(F) = 0.027) with marginal zone lymphoma that is significant after correction for multiple testing.
|
22347493 |
2012 |
rs928883
|
MIR155HG
|
Marginal Zone B-Cell Lymphoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Variant rs928883, near miR-155, showed an association (OR per A-allele: 2.80 [95% CI: 1.63-4.82]; p(F) = 0.027) with marginal zone lymphoma that is significant after correction for multiple testing.
|
22347493 |
2012 |
rs12483428
|
MIR155HG
|
Epilepsy
|
|
0.010 |
GeneticVariation |
BEFREE |
The TCA haplotype (rs12483428-rs987195-rs4817027) and the AA genotype at rs4817027 conferred higher vulnerability to epilepsy in males.
|
26425555 |
2015 |
rs4817027
|
MIR155HG
|
Epilepsy
|
|
0.010 |
GeneticVariation |
BEFREE |
The TCA haplotype (rs12483428-rs987195-rs4817027) and the AA genotype at rs4817027 conferred higher vulnerability to epilepsy in males.
|
26425555 |
2015 |
rs4817027
|
MIR155HG
|
Drug Resistant Epilepsy
|
|
0.010 |
GeneticVariation |
BEFREE |
Further stratification by drug-resistant status indicated the CC haplotype (rs969885-rs987195) and the AA genotype at rs4817027 were genetic susceptibility factors for drug-resistant epilepsy (DRE) but the CG haplotype (rs987195-rs969885) was a genetically protective factor against DRE.
|
26425555 |
2015 |
rs987195
|
MIR155HG
|
Drug Resistant Epilepsy
|
|
0.010 |
GeneticVariation |
BEFREE |
Further stratification by drug-resistant status indicated the CC haplotype (rs969885-rs987195) and the AA genotype at rs4817027 were genetic susceptibility factors for drug-resistant epilepsy (DRE) but the CG haplotype (rs987195-rs969885) was a genetically protective factor against DRE.
|
26425555 |
2015 |
rs987195
|
MIR155HG
|
Epilepsy
|
|
0.010 |
GeneticVariation |
BEFREE |
The TCA haplotype (rs12483428-rs987195-rs4817027) and the AA genotype at rs4817027 conferred higher vulnerability to epilepsy in males.
|
26425555 |
2015 |
rs767649
|
MIR155HG;MIR155
|
Adenocarcinoma of lung (disorder)
|
|
0.010 |
GeneticVariation |
BEFREE |
Furthermore, using functional assays and The Cancer Genome Atlas (TCGA) Lung Adenocarcinoma (LUAD) dataset, we found that rs767649 variant allele could increase the transcriptional activity of miR-155, which in turn facilitated tumor growth and metastasis by inhibiting HBP1, TJP1, SMAD5 and PRKAR1A expression.
|
26543233 |
2015 |
rs767649
|
MIR155HG;MIR155
|
Neoplasm Metastasis
|
|
0.010 |
GeneticVariation |
BEFREE |
Furthermore, using functional assays and The Cancer Genome Atlas (TCGA) Lung Adenocarcinoma (LUAD) dataset, we found that rs767649 variant allele could increase the transcriptional activity of miR-155, which in turn facilitated tumor growth and metastasis by inhibiting HBP1, TJP1, SMAD5 and PRKAR1A expression.
|
26543233 |
2015 |
rs767649
|
MIR155HG;MIR155
|
Non-Small Cell Lung Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings suggested that rs767649 A > T might contribute to the increased risk and poor prognosis of NSCLC, highlighting the importance of rs767649 in the prevention and therapy of NSCLC.
|
26543233 |
2015 |
rs767649
|
MIR155HG;MIR155
|
Liver carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings suggested that miR-155 and its functional variant rs767649 might contribute to the increased risk and poor prognosis of HCC, highlighting the importance of miR-155 in the prevention and prognosis of HCC.
|
27531892 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Malignant neoplasm of lung
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs767649 polymorphism, locating in the promoter of miR-155, was recently reported to be able to alter transcriptional activity of miR-155 and relate to lung cancer risk.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
cervical cancer
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, rs767649 might be a causal variant for CC susceptibility.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Carcinoma of lung
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs767649 polymorphism, locating in the promoter of miR-155, was recently reported to be able to alter transcriptional activity of miR-155 and relate to lung cancer risk.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Primary malignant neoplasm of lung
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs767649 polymorphism, locating in the promoter of miR-155, was recently reported to be able to alter transcriptional activity of miR-155 and relate to lung cancer risk.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Malignant tumor of cervix
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, rs767649 might be a causal variant for CC susceptibility.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Cervix carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, rs767649 might be a causal variant for CC susceptibility.
|
27717891 |
2016 |
rs767649
|
MIR155HG;MIR155
|
Diabetes Mellitus, Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
MiR-146a rs2910164 and miR-155 rs767649 polymorphisms were associated with protection for T1DM.
|
28101643 |
2017 |
rs767649
|
MIR155HG;MIR155
|
Multiple Sclerosis
|
|
0.010 |
GeneticVariation |
BEFREE |
This study was conducted to investigate the association between mir155 rs767649, mir196a2 rs11614913 and mir23a rs3745453 polymorphism and the risk of multiple sclerosis in the Iranian MS patients in Isfahan.
|
30518189 |
2018 |
rs767649
|
MIR155HG;MIR155
|
Rheumatoid Arthritis
|
|
0.010 |
GeneticVariation |
BEFREE |
MiR-155 and IMA levels were significantly associated with the genotype distribution of miR-155 (rs767649) in patients with RA and were higher in patients with the TT genotype.
|
31009294 |
2019 |
rs12482371
|
MIR155HG
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Genetic model analysis revealed that rs12482371 and rs1893650 increased CRC risk; whereas rs928883 was associated with reduced CRC risk.
|
31228357 |
2019 |
rs1893650
|
MIR155HG
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Rs12482371 and rs1893650 were associated with the CRC</span> risk in</span> females.
|
31228357 |
2019 |
rs34904192
|
MIR155HG
|
Secondary malignant neoplasm of lymph node
|
|
0.010 |
GeneticVariation |
BEFREE |
Rs11911469 and rs34904192 may affect the clinical stage and lymph node metastasis.
|
31228357 |
2019 |
rs928883
|
MIR155HG
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Genetic model analysis revealed that rs12482371 and rs1893650 increased CRC risk; whereas rs928883 was associated with reduced CRC risk.
|
31228357 |
2019 |
rs767649
|
MIR155HG;MIR155
|
Intracranial Aneurysm
|
|
0.010 |
GeneticVariation |
BEFREE |
The results of this study showed that the SNP rs767649 in the promoter of miR-155 could reduce the transcription activity of miR-155, while poorly expressed miR-155 could increase the incidence of IA rupture by increasing the expression of MMP-2, especially in subjects carrying the TT genotype of SNP rs767649.
|
31338876 |
2019 |